Related Experiment Videos
Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 beta-converting enzyme precursor
P Ramage1, D Cheneval, M Chvei
1Department of Biotechnology, Sandoz Pharma Ltd., Basel, Switzerland.
The Journal of Biological Chemistry
|April 21, 1995
Summary
Interleukin-1 beta-converting enzyme (ICE) is a protease produced as a precursor. Inhibitors and nonreducing conditions blocked its conversion to active subunits, revealing a potential regulatory role for the N-terminal portion.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Interleukin-1 beta-converting enzyme (ICE) is a cysteine protease involved in apoptosis.
- ICE is synthesized as a 45-kDa inactive precursor.
- Understanding ICE processing is crucial for its role in biological pathways.
Purpose of the Study:
- To investigate the autoproteolytic processing and activation of the interleukin-1 beta-converting enzyme precursor.
- To identify factors influencing the conversion of the 45-kDa ICE precursor to its active heterodimeric form.
- To explore the potential regulatory role of the ICE precursor's N-terminal region.
Main Methods:
- Expression of full-length ICE precursor in Escherichia coli.
- Solubilization and refolding of the expressed protein.
- Analysis of proteolytic processing using inhibitors and varying refolding conditions.
- Time-course studies to determine subunit processing order.
Main Results:
- Autoproteolytic conversion of the 45-kDa ICE precursor to a 10- and 20-kDa heterodimeric form was observed upon refolding.
- Catalytic activity was confirmed against interleukin-1 beta precursor and synthetic substrates.
- Inclusion of a specific inhibitor (SDZ 223-941) or refolding under nonreducing conditions prevented processing to the active form.
- Time-course experiments indicated sequential release of the 10-kDa subunit before the 20-kDa subunit.
Conclusions:
- The interleukin-1 beta-converting enzyme precursor undergoes autoproteolytic processing to generate its active heterodimeric form.
- Specific inhibitors and nonreducing conditions can block this activation process.
- The sequential release of subunits suggests a regulatory role for the N-terminal portion of the precursor, which is released last.